Mirati Therapeutics, Inc.
NASDAQ:MRTX
58.7 (USD) • At close January 22, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12.436 | 72.092 | 13.398 | 3.335 | 12.926 | 0 | 0 | 0 | 0 | 0 | 0.002 | 3.028 | 2.389 | 2.884 | 24.236 | 15.653 | 13.749 | 5.758 | 7.682 | 7.711 |
| Cost of Revenue
| 0.6 | 508.594 | 299.349 | 182.866 | 93.872 | 58.085 | 68.487 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 11.836 | -436.502 | -285.951 | -179.531 | -80.946 | -58.085 | -68.487 | 0 | 0 | 0 | 0.002 | 3.028 | 2.389 | 2.884 | 24.236 | 15.653 | 13.749 | 5.758 | 7.682 | 7.711 |
| Gross Profit Ratio
| 0.952 | -6.055 | -21.343 | -53.832 | -6.262 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 531.627 | 508.594 | 299.349 | 182.866 | 93.872 | 58.085 | 68.487 | 48.959 | 26.071 | 19.797 | 15.137 | 8.473 | 10.872 | 20.014 | 29.331 | 33.127 | 17.811 | 14.882 | 12.277 | 8.103 |
| General & Administrative Expenses
| 0 | 136.679 | 83.412 | 42.573 | 21.681 | 13.45 | 15.292 | 15.755 | 12.699 | 11.144 | 5.414 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 239.798 | 136.679 | 83.412 | 42.573 | 21.681 | 13.45 | 15.292 | 15.755 | 12.699 | 11.144 | 5.414 | 4.201 | 6.206 | 5.056 | 4.549 | 4.956 | 4.275 | 4.2 | 3.868 | 2.741 |
| Other Expenses
| 19.23 | -5.304 | 11.426 | 8.848 | 4.209 | 1.105 | 0.661 | 0.17 | -4.594 | 1.025 | -0 | 0.138 | 0.019 | 0.377 | -0.849 | 0.017 | -5.111 | 0.042 | 0.046 | 0.989 |
| Operating Expenses
| 771.425 | 645.273 | 382.761 | 225.439 | 115.553 | 71.535 | 83.779 | 64.714 | 38.77 | 30.941 | 20.551 | 12.812 | 17.097 | 25.447 | 33.031 | 38.101 | 16.976 | 19.124 | 16.19 | 11.833 |
| Operating Income
| -759.589 | -573.181 | -369.363 | -222.104 | -102.627 | -71.535 | -83.779 | -64.714 | -39.104 | -31.966 | -20.549 | -9.784 | -14.709 | -22.563 | -8.795 | -22.448 | -3.227 | -13.365 | -8.509 | -4.122 |
| Operating Income Ratio
| -61.08 | -7.951 | -27.569 | -66.598 | -7.94 | 0 | 0 | 0 | 0 | 0 | -10,221.5 | -3.231 | -6.158 | -7.823 | -0.363 | -1.434 | -0.235 | -2.321 | -1.108 | -0.535 |
| Total Other Income Expenses Net
| 19.23 | -5.304 | 11.426 | 8.848 | 4.209 | 1.105 | 0.661 | 0.17 | -4.928 | -21.908 | 0.178 | 0 | 0.024 | 0.162 | 1.303 | 0.21 | 2.057 | 0.2 | -0.582 | 0 |
| Income Before Tax
| -740.359 | -578.485 | -357.937 | -213.256 | -98.418 | -70.43 | -83.118 | -64.544 | -43.698 | -52.882 | -20.32 | 0 | -14.685 | -22.401 | -7.492 | -22.238 | -1.17 | -13.165 | -9.09 | -4.122 |
| Income Before Tax Ratio
| -59.534 | -8.024 | -26.716 | -63.945 | -7.614 | 0 | 0 | 0 | 0 | 0 | -10,107.5 | 0 | -6.148 | -7.767 | -0.309 | -1.421 | -0.085 | -2.286 | -1.183 | -0.535 |
| Income Tax Expense
| 0.508 | 3.299 | -0.511 | -0.659 | 4.209 | -0.13 | -0.155 | -0.249 | 0.121 | -0.023 | 0.039 | -0.257 | 0.004 | 0.128 | -0.114 | -3.101 | 5.275 | -0.763 | 0.057 | 0.1 |
| Net Income
| -740.867 | -581.784 | -357.426 | -212.597 | -98.418 | -70.484 | -83.143 | -64.507 | -43.684 | -52.872 | -20.359 | -9.527 | -14.689 | -22.529 | -7.378 | -22.238 | -6.445 | -13.165 | -9.147 | -4.222 |
| Net Income Ratio
| -59.574 | -8.07 | -26.678 | -63.747 | -7.614 | 0 | 0 | 0 | 0 | 0 | -10,127 | -3.146 | -6.149 | -7.811 | -0.304 | -1.421 | -0.469 | -2.286 | -1.191 | -0.548 |
| EPS
| -13.18 | -11.21 | -7.94 | -5.67 | -3.19 | -2.79 | -4.2 | -3.82 | -3.24 | -4.78 | -2.04 | -1.5 | -18.17 | -30.04 | -10.06 | -31.11 | -11.36 | -30.29 | -24.08 | -12.78 |
| EPS Diluted
| -13.18 | -11.21 | -7.94 | -5.67 | -3.19 | -2.79 | -4.2 | -3.82 | -3.24 | -4.78 | -2.04 | -1.5 | -18.17 | -30.04 | -10.06 | -31.11 | -11.36 | -30.29 | -24.08 | -12.78 |
| EBITDA
| -756.66 | -571.4 | -368.722 | -222.104 | -102.627 | -71.535 | -83.779 | -64.714 | 2.014 | -31.966 | -20.375 | -9.594 | -13.951 | -21.43 | -6.371 | -20.971 | -1.945 | -12.268 | -7.235 | -3.295 |
| EBITDA Ratio
| -61.08 | -7.951 | -27.569 | -66.598 | -7.94 | 0 | 0 | 0 | 0 | 0 | -10,024.5 | -3.168 | -5.841 | -7.43 | -0.263 | -1.34 | -0.141 | -2.131 | -0.942 | -0.427 |